Patent · US Active

Antibody-drug conjugates and uses thereof

US11384150B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 13, 2017
Grant dateJul 12, 2022
Priority date—
Expiry dateFeb 26, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An immunoconjugate, comprising an anti-EGFR antibody or a binding fragment thereof, and a kinase inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.